Mirion Technologies (NYSE:MIR) (NYSE: MIR) is a global provider of radiation detection, measurement and monitoring solutions serving the medical, nuclear power, defense, industrial and environmental markets. The company’s portfolio includes instrumentation, software, integrated systems and services designed to detect and analyze radiation levels, support patient safety in medical settings and ensure regulatory compliance across a wide range of industries.
Formed in 2011 through the combination of Mirion and Canberra, the company has grown through strategic acquisitions and organic investment to broaden its technological capabilities. Over the years, Mirion has integrated complementary product lines—from scintillation detectors and dosimeters to advanced data acquisition systems—enabling customers to address complex challenges in radiation management and nuclear imaging.
Mirion operates in more than 25 countries, with major R&D and manufacturing facilities in North America, Europe and Asia. Its global footprint includes engineering centers in the United States, France, Germany and China, supported by a network of sales, service and technical support teams that deliver solutions to hospitals, nuclear utilities, government agencies and industrial customers worldwide.
Under the leadership of Chief Executive Officer Jay Bewley and an experienced executive team, Mirion is focused on innovation, quality and customer service. The company emphasizes continuous R&D investment and strategic partnerships to advance its product offerings, strengthen its market position and address emerging needs in radiation safety and measurement technology.
